During the past decade, Fukuyama City Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukuyama City Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Japan Clinical Cancer Research Organization" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukuyama City Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Fukuyama City Hospital" are "Atopic Dermatitis" (2 trials), "Gastric Cancer" (2 trials), "Heart Failure" (2 trials), "Respiratory Syncytial Virus Infections" (2 trials) and "Advanced Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Fukuyama City Hospital" in a lesser frequency.

Most popular intervention types in "Fukuyama City Hospital" are "Drug" (15 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "Lumicitabine" (2 trials), "S-1" (2 trials) and "Topical corticosteroid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fukuyama City Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Fukuyama City Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Fukuyama City Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fukuyama City Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".